Advertisement

Index by author

March 01, 1987; Volume 240,Issue 3

  1. Schneider, J

    1. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
      J Lehmann, J Schneider, S McPherson, D E Murphy, P Bernard, C Tsai, D A Bennett, G Pastor, D J Steel and C Boehm
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 737-746;
    2. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
      D E Murphy, J Schneider, C Boehm, J Lehmann and M Williams
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 778-784;

  2. Schnoor, J

    1. Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat.
      S Szabo, H C Horner, H Maull, J Schnoor, C C Chiueh and M Palkovits
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 871-878;

  3. Shibanoki, S

    1. Comparative study of phenothiazine derivatives on monoamine metabolism--direct correlation between the concentrations of drugs and monoamine metabolites in the brain.
      S Shibanoki, T Kubo and K Ishikawa
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 959-965;

  4. Shook, J E

    1. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
      J E Shook, J T Pelton, W S Wire, L D Hirning, V J Hruby and T F Burks
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 772-777;

  5. Skingle, M

    1. Evaluation of the receptor selectivities of opioid drugs by investigating the block of their effect on urine output by beta-funaltrexamine.
      A G Hayes, M Skingle and M B Tyers
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 984-988;

  6. Skolnick, P

    1. Aldosterone-reversible decrease in the density of renal peripheral benzodiazepine receptors in the rat after adrenalectomy.
      A S Basile, N L Ostrowski and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 1006-1013;
    2. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
      G T Bolger, K A Marcus, J W Daly and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 922-930;

  7. Smallwood, R A

    1. Hypoxia impairs conjugation and elimination of harmol in the isolated perfused rat liver.
      P W Angus, G W Mihaly, D J Morgan and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 931-936;

  8. Spector, R

    1. Transport of diphenhydramine in the central nervous system.
      M J Goldberg, R Spector and C K Chiang
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 717-722;

  9. Steel, D J

    1. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
      J Lehmann, J Schneider, S McPherson, D E Murphy, P Bernard, C Tsai, D A Bennett, G Pastor, D J Steel and C Boehm
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 737-746;

  10. Stratford, C A

    1. Ascorbic acid prevents nonreceptor "specific" binding of [3H]-5-hydroxytryptamine to bovine cerebral cortex membranes.
      M W Hamblin, P I Adriaenssens, K Ariani, R M Cawthon, C A Stratford, G L Tan and R D Ciaranello
      Journal of Pharmacology and Experimental Therapeutics March 1987, 240 (3) 701-711;
« Previous (Pages : 10 11 12 13 14 15 16 ... 16) Next »
Back to top

In this issue

Advertisement